Home > PJ (current issue) > Products | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7474 p435
20 October 2007

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader


Announcements


Announcements

Intravenous ciclosporin
The dose of intravenous ciclosporin for the treatment of refractory ulcerative colitis in children is incorrect on p469 of the British National Formulary 54 and on p74 of the BNF for Children 2007. The dose by intravenous infusion should read: “Child 3–18 years: initially 0.5–1mg/kg twice daily; dose adjusted according to blood-ciclosporin concentration and response”. The error will be corrected in BNFC 2008 and BNF 55 (March 2008).

Electronic prescriptions
Maintenance work will be taking place from 10pm on 9 November until 10am on 11 November on the NHS Spine, the backbone of the NHS Care Records Service which supports various systems and services, including the Electronic prescription service. During this time it will not be possible for prescribers to issue prescriptions with barcodes on them and it will not be possible for pharmacies to pull down prescription messages from the spine.

Prescribers will need to revert to printing non-EPS (non-barcoded) prescriptions and pharmacies will need to revert to manual inputting of prescription items from the FP10 into their local systems.

Further information

Metoject
Metoject (methotrexate) will now be delivered to community pharmacies, dispensing GPs and home care patients free of charge. Metoject is now included on the list of Zero Discount products in the Drug Tariff and so the discount previously applied has ceased and pharmacists should mark prescriptions “ZD” (zero discount).

Back to Top


©The Pharmaceutical Journal